Babies' DNA affects mothers' risk of pre-eclampsia in pregnancy, study finds

   
   
Pre-eclampsia-PR
19 Jun 2017 16:00:00.000

PA129/17

A major new international study has revealed for the first time that some features in a baby’s DNA can increase the risk of its mother developing pre-eclampsia – a potentially dangerous condition in pregnancy. 

These results from the InterPregGen study are published in Nature Genetics. The work was carried out by genetics experts from the UK, Nordic countries and Central Asia and is the first to show an effect of DNA from the fetus on the health of its mother. 

Pre-eclampsia affects up to 5% of pregnancies and is first suspected when a woman is found to have high blood pressure, usually in the second half of pregnancy. The condition can cause serious complications including fits, stroke, liver and blood problems and in some cases the death of mother and baby.  

Click here for full story

The 5-year study involved teams from the UK, Iceland, Finland, Norway, Kazakhstan and Uzbekistan. They studied the genetic make-up of 4,380 babies born from pre-eclamptic pregnancies and compared their DNA with over 300,000 healthy individuals.  

Dr Linda Morgan, from the University of Nottingham’s School of Life Sciences, coordinated the 5-year study, which included DNA samples contributed from Iceland, Norway and Finland as well as from over 20 universities and maternity units in the UK. 

Dr Morgan says: “For many years midwives and obstetricians have known that a woman is more likely to develop pre-eclampsia if her mother or sister had the disorder. More recently research has shown that the condition also runs in the families of men who father pre-eclamptic pregnancies. We knew that faulty formation of the placenta is often found in pre-eclampsia. As it is the baby’s genes that produce the placenta we set out to see if we could find a link between the baby’s DNA and the condition. We found there were indeed some features in a baby’s DNA that can increase the risk of pre-eclampsia.” 

Laboratory and statistical analysis performed at the Wellcome Trust Sanger Institute (UK) and deCODE Genetics (Iceland) pinpointed the location in the baby’s DNA that increases risk of pre-eclampsia. This location was confirmed by other InterPregGen members to fit hand-in-glove with other medical information about pre-eclampsia. 

Dr Ralph McGinnis, who led the analysis at the Sanger Institute, said: “Pre-eclampsia has been recognized since ancient Egypt and Greece as being a danger to the lives of mothers and babies.  This first piece of the genetic jigsaw holds substantial promise for unlocking some of the mystery of how pre-eclampsia is caused.  Our finding may also enable better prediction of mothers who will become pre-eclamptic when combined with clinical information and with other pieces of the genetic jigsaw that will also surely be discovered in the next few years.” 

The baby’s DNA comes from both its mother’s and its father’s genes – in keeping with the inherited risk of pre-eclampsia. The DNA changes associated with pre-eclampsia are common – over 50% of people carry this sequence in their DNA so the inherited changes are not sufficient in themselves to cause disease, but they do increase the risk of pre-eclampsia. 

The research found DNA variations close to the gene that makes a protein called sFlt-1 with significant differences between the babies born from pre-eclamptic pregnancies and the control group. At high levels sFlt-1 released from the placenta into the mother’s bloodstream can cause damage to her blood vessels, leading to high blood pressure and damage to her kidneys, liver and brain – all features of pre-eclampsia. If a baby carried these genetic variants it increased the risk of that pregnancy being pre-eclamptic.

Dr Morgan concludes: “Because pre-eclampsia has its origins in the very early stages of pregnancy, during the formation of the placenta, research into the causes and processes of the disease has always been challenging. Now modern genome wide screening and its data analysis allows us to look for clues in the mother’s, father’s and their baby’s DNA. We believe the new insights from this study could form the basis for more effective prevention and treatment of pre-eclampsia in the future, and improve the outcome of pregnancy for mother and child.”

DNA from a further 4,220 babies from pre-eclamptic pregnancies in Kazakhstan and Uzbekistan is currently being analysed in an extended study to see if the same variations occur near sFlt-1.  

The research was funded by a 6 million Euro grant from the European Commission.

— Ends —

Our academics can now be interviewed for broadcast via our Media Hub, which offers a Globelynx fixed camera and ISDN line facilities at University Park campus. For further information please contact a member of the Communications team on +44 (0)115 951 5798, email mediahub@nottingham.ac.uk or see the Globelynx website for how to register for this service.

For up to the minute media alerts, follow us on Twitter

Notes to editors: The University of Nottingham has 43,000 students and is ‘the nearest Britain has to a truly global university, with a “distinct” approach to internationalisation, which rests on those full-scale campuses in China and Malaysia, as well as a large presence in its home city.’ (Times Good University Guide 2016). It is also one of the most popular universities in the UK among graduate employers and was named University of the Year for Graduate Employment in the 2017 The Times and The Sunday Times Good University Guide. It is ranked in the world’s top 75 by the QS World University Rankings 2015/16, and 8th in the UK for research power according to the Research Excellence Framework 2014. It has been voted the world’s greenest campus for four years running, according to Greenmetrics Ranking of World Universities.

Impact: The Nottingham Campaign, its biggest-ever fundraising campaign, is delivering the University’s vision to change lives, tackle global issues and shape the future. More news…

 

Story credits

More information is available from Associate Professor Linda Morgan via email linda.morgan@nottingham.ac.uk 

EmmaRayner2

Emma Rayner - Media Relations Manager

Email: emma.rayner@nottingham.ac.uk Phone: +44 (0)115 951 5793 Location: University Park

Additional resources

No additional resources for this article

Media Relations - External Relations

The University of Nottingham
C Floor, Pope Building (Room C4)
University Park
Nottingham, NG7 2RD

telephone: +44 (0) 115 951 5798
email: communications@nottingham.ac.uk